20 May 2021

During this hour-long panel discussion at Bio Integrates 2021, tranScrip's Managing Partner, Flic Gabbay, joined other health care professionals to discuss how to accelerate the development, assessment and approval of medicines outside of a pandemic. 

Facilitated by:
Ian Muir, Chief Executive Officer, Porton Biopharma

Speakers included:
Paul Stott, Chief Executive Office, Seda Pharmaceutical Development Services
- Jill Reckless, Chief Executive Officer, RxCelerate
- Flic Gabbay, Managing Partner, tranScrip
- Sandy Douglas, Research Group Leader, The University of Oxford
- Nick Smith, Associate Director of Operations, Cobra Biologics

You can view all Bio Intergates 2021 recordings here.